CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in TVTX — Travere Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in TVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,997,663
+$23,502,639 QoQ
Shares Held
827,278
+4.6% QoQ
Ownership
0.878%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#32
of 315 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. TVTX ranks #38 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in TVTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,997,663 | 827,278 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $23,495,024 | 790,812 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,880,901 | 808,189 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,275,708 | 848,356 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $11,415,180 | 771,296 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $12,267,010 | 684,543 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $11,525,124 | 661,603 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $7,938,051 | 567,409 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,673,834 | 568,593 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,282,689 | 555,472 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $4,849,988 | 539,487 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $5,059,315 | 565,919 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,299,822 | 540,353 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $11,297,401 | 502,330 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,739,224 | 463,111 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $11,404,426 | 462,842 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,391,661 | 470,147 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $12,160,347 | 471,880 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $14,226,252 | 458,320 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $11,249,065 | 463,879 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $9,339,277 | 640,115 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $16,870,980 | 675,650 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $15,216,739 | 558,310 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 RTRX | — | 523,602 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 RTRX | — | 403,354 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 RTRX | — | 346,062 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||